Forward from: انجمن سلولهای بنیادی کرمانشاه
•FIRST NON-HODKIN CONFERENCE IN WEST OF IRAN :
•khordad, 2 , 1398
•imam reza hospital Kermanshah
Programme agenda:
: 08.00 -1200
introduction-mehrdad payandeh , Clinical Hematologist - Medical Oncologist (KUMS).
8-8:15
Session I:(8:15-10)
1-Genetic study in lymphomas – Reza Alibakhshi , Clinical Genetic (KUMS). 8:15-8:30
2-Genomic data in AML and which mutations matter -kamran mansori molecular spectialist -Medical Oncologist (KUMS). 8:30-8:45
3-infective disease as precursor of NHL-mohamad-hossein zamanian , Clinical infective specialist ( KUM). 8:45-9
4-Managing the toxicities of CAR T-cell therapy – Forod Shahbazi , Clinical Pharmacist (KUMS).
9-9:15
5-What we should know about NK/T-cell lymphomas – Mehdi Taghadosi , Clinical Immunologist (KUMS) .9:15-9:30
6-Cutaneous lymphomas – Mazaher Ramezani, Dermatology pathologist (KUMS) .9:30-9:45
7-infective disease as precursor of NHL-mohamad-hossein zamanian , Clinical infective specialist ( KUM).9:45-10
Session II: (10:15-12)
8-Liquid biopsy: a clinical tool, already? – Abolghasem Mirbahari . Clinical Pathologist (KUMS).
10:15-10:30
9-Double Hit lymphoma, so what? – Hamid Madani , Clinical Pathologist (KUMS).
10:30-10:45
10-Breast implant associated ALCL and other rare T-cell lymphomas – Arash Golpazir , Surgical Oncologist (KUMS).
10:45-11
11-Multiple myeloma: every year a new standard? – Hassan Normohamadi , Clinical Hematologist - Medical Oncologist (IUMS).
11-11:15
12-The modern approach to mantle cell lymphoma – Bayazid Ghaderi , Clinical Hematologist - Medical Oncologist (SUMS).
11:15-11:30
13-Hairy Cell leukemia, new treatment options – Ronak Naleini , Clinical Hematologist - Medical Oncologist (KUMS).
11:30-11:45
14-Flowcytometery in lymphoma-leukemia, ali maleki , laboratory hematologist-(KUMS).
11:45-12
@kums_sc
•khordad, 2 , 1398
•imam reza hospital Kermanshah
Programme agenda:
: 08.00 -1200
introduction-mehrdad payandeh , Clinical Hematologist - Medical Oncologist (KUMS).
8-8:15
Session I:(8:15-10)
1-Genetic study in lymphomas – Reza Alibakhshi , Clinical Genetic (KUMS). 8:15-8:30
2-Genomic data in AML and which mutations matter -kamran mansori molecular spectialist -Medical Oncologist (KUMS). 8:30-8:45
3-infective disease as precursor of NHL-mohamad-hossein zamanian , Clinical infective specialist ( KUM). 8:45-9
4-Managing the toxicities of CAR T-cell therapy – Forod Shahbazi , Clinical Pharmacist (KUMS).
9-9:15
5-What we should know about NK/T-cell lymphomas – Mehdi Taghadosi , Clinical Immunologist (KUMS) .9:15-9:30
6-Cutaneous lymphomas – Mazaher Ramezani, Dermatology pathologist (KUMS) .9:30-9:45
7-infective disease as precursor of NHL-mohamad-hossein zamanian , Clinical infective specialist ( KUM).9:45-10
Session II: (10:15-12)
8-Liquid biopsy: a clinical tool, already? – Abolghasem Mirbahari . Clinical Pathologist (KUMS).
10:15-10:30
9-Double Hit lymphoma, so what? – Hamid Madani , Clinical Pathologist (KUMS).
10:30-10:45
10-Breast implant associated ALCL and other rare T-cell lymphomas – Arash Golpazir , Surgical Oncologist (KUMS).
10:45-11
11-Multiple myeloma: every year a new standard? – Hassan Normohamadi , Clinical Hematologist - Medical Oncologist (IUMS).
11-11:15
12-The modern approach to mantle cell lymphoma – Bayazid Ghaderi , Clinical Hematologist - Medical Oncologist (SUMS).
11:15-11:30
13-Hairy Cell leukemia, new treatment options – Ronak Naleini , Clinical Hematologist - Medical Oncologist (KUMS).
11:30-11:45
14-Flowcytometery in lymphoma-leukemia, ali maleki , laboratory hematologist-(KUMS).
11:45-12
@kums_sc